- Home
- Publications
- Publication Search
- Publication Details
Title
Trials with ‘epigenetic’ drugs: An update
Authors
Keywords
-
Journal
Molecular Oncology
Volume 6, Issue 6, Pages 657-682
Publisher
Wiley
Online
2012-10-07
DOI
10.1016/j.molonc.2012.09.004
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Myelodysplastic syndromes: 2012 update on diagnosis, risk-stratification, and management
- (2012) Guillermo Garcia-Manero AMERICAN JOURNAL OF HEMATOLOGY
- Different Involvement of DNA Methylation and Histone Deacetylation in the Expression of Solute-Carrier Transporters in 4 Colon Cancer Cell Lines
- (2012) Mika Ikehata et al. BIOLOGICAL & PHARMACEUTICAL BULLETIN
- Allogeneic Hematopoietic Cell Transplantation in Patients Age 60-70 Years with De Novo High-Risk Myelodysplastic Syndrome or Secondary Acute Myelogenous Leukemia: Comparison with Patients Lacking Donors Who Received Azacitidine
- (2012) Uwe Platzbecker et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Combination of HDAC and topoisomerase inhibitors in small cell lung cancer
- (2012) Jhanelle Gray et al. CANCER BIOLOGY & THERAPY
- MG98, a Second-Generation DNMT1 Inhibitor, in the Treatment of Advanced Renal Cell Carcinoma
- (2012) Robert J. Amato et al. CANCER INVESTIGATION
- Phase I/II study of decitabine in patients with myelodysplastic syndrome: A multi-center study in Japan
- (2012) Yasuhiro Oki et al. CANCER SCIENCE
- A Phase I Pharmacokinetic and Pharmacodynamic Study of CHR-3996, an Oral Class I Selective Histone Deacetylase Inhibitor in Refractory Solid Tumors
- (2012) U. Banerji et al. CLINICAL CANCER RESEARCH
- Romidepsin for Cutaneous T-cell Lymphoma
- (2012) H. M. Prince et al. CLINICAL CANCER RESEARCH
- An Epigenetic Approach to Pancreatic Cancer Treatment: The Prospective Role of Histone Deacetylase Inhibitors
- (2012) Nicola Tinari et al. CURRENT CANCER DRUG TARGETS
- Derivatives of Resveratrol: Potential Agents in Prevention and Treatment of Cardiovascular Disease
- (2012) Ban-Feng Ruan et al. CURRENT MEDICINAL CHEMISTRY
- Chemoprevention with Phytonutrients and Microalgae Products in Chronic Inflammation and Colon Cancer
- (2012) Elena Talero et al. CURRENT PHARMACEUTICAL DESIGN
- Azacitidine
- (2012) Gillian M. Keating DRUGS
- Curcumin and neurodegenerative diseases: a perspective
- (2012) Altaf S Darvesh et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Decitabine for acute myeloid leukemia
- (2012) Peter W Marks Expert Review of Anticancer Therapy
- Comprehensive DNA methylation analysis of benign and malignant adrenocortical tumors
- (2012) Annabelle L. Fonseca et al. GENES CHROMOSOMES & CANCER
- The impact of curcumin on breast cancer
- (2012) Ganji Purnachandra Nagaraju et al. Integrative Biology
- SIRT1, Is It a Tumor Promoter or Tumor Suppressor?
- (2012) Chu-Xia Deng International Journal of Biological Sciences
- A phase I study of oral panobinostat (LBH589) in Japanese patients with advanced solid tumors
- (2012) Akira Fukutomi et al. INVESTIGATIONAL NEW DRUGS
- Results From a Pivotal, Open-Label, Phase II Study of Romidepsin in Relapsed or Refractory Peripheral T-Cell Lymphoma After Prior Systemic Therapy
- (2012) Bertrand Coiffier et al. JOURNAL OF CLINICAL ONCOLOGY
- Promoter methylation regulates cigarette smoke-stimulated cyclooxygenase-2 expression in esophageal squamous cell carcinoma
- (2012) Xin Ying MENG et al. Journal of Digestive Diseases
- Decitabine and Vorinostat Cooperate To Sensitize Colon Carcinoma Cells to Fas Ligand-Induced Apoptosis In Vitro and Tumor Suppression In Vivo
- (2012) D. Yang et al. JOURNAL OF IMMUNOLOGY
- Defining the Mechanism of Action and Enzymatic Selectivity of Psammaplin A against Its Epigenetic Targets
- (2012) Matthias G. J. Baud et al. JOURNAL OF MEDICINAL CHEMISTRY
- A dynamic multi-compartmental model of DNA methylation with demonstrable predictive value in hematological malignancies
- (2012) Andrew P. McGovern et al. JOURNAL OF THEORETICAL BIOLOGY
- Vorinostat combined with bexarotene for treatment of cutaneous T-cell lymphoma:in vitroand phase I clinical evidence supporting augmentation of retinoic acid receptor/retinoid X receptor activation by histone deacetylase inhibition
- (2012) Reinhard Dummer et al. LEUKEMIA & LYMPHOMA
- Histone methylation: a dynamic mark in health, disease and inheritance
- (2012) Eric L. Greer et al. NATURE REVIEWS GENETICS
- Protective Effects of Curcumin on Amyloid-β-Induced Neuronal Oxidative Damage
- (2012) Han-Chang Huang et al. NEUROCHEMICAL RESEARCH
- Inclusion Complex of Novel Curcumin Analogue CDF and β-Cyclodextrin (1:2) and Its Enhanced In Vivo Anticancer Activity Against Pancreatic Cancer
- (2012) Prasad R. Dandawate et al. PHARMACEUTICAL RESEARCH
- Methylation Markers of Early-Stage Non-Small Cell Lung Cancer
- (2012) Kaie Lokk et al. PLoS One
- The oral HDAC inhibitor pracinostat (SB939) is efficacious and synergistic with the JAK2 inhibitor pacritinib (SB1518) in preclinical models of AML
- (2012) V Novotny-Diermayr et al. Blood Cancer Journal
- Effect of novel water soluble curcumin derivative on experimental type- 1 diabetes mellitus (short term study)
- (2012) Mohamed T Abdel Aziz et al. Diabetology & Metabolic Syndrome
- Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: preclinical and clinical observations
- (2012) Manjeshwar Shrinath Baliga et al. Food & Function
- Safety and efficacy of azacitidine in the treatment of elderly patients with myelodysplastic syndrome
- (2012) Ellen Ritchie Clinical Interventions in Aging
- Sirtuins and Disease: The Road Ahead
- (2012) Vincenzo Carafa et al. Frontiers in Pharmacology
- Phase II study of the histone deacetylase inhibitor belinostat (PXD101) for the treatment of myelodysplastic syndrome (MDS)
- (2011) Amanda Cashen et al. ANNALS OF HEMATOLOGY
- Chemosensitization of tumors by resveratrol
- (2011) Subash C. Gupta et al. Annals of the New York Academy of Sciences
- Curcumin regulates airway epithelial cell cytokine responses to the pollutant cadmium
- (2011) Jessica Rennolds et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Safety of long-term treatment of HAM/TSP patients with valproic acid
- (2011) S. Olindo et al. BLOOD
- Phase 2 trial of romidepsin in patients with peripheral T-cell lymphoma
- (2011) R. L. Piekarz et al. BLOOD
- A pilot study of subcutaneous decitabine in -thalassemia intermedia
- (2011) N. F. Olivieri et al. BLOOD
- Phase I clinical, pharmacokinetic and pharmacodynamic study of SB939, an oral histone deacetylase (HDAC) inhibitor, in patients with advanced solid tumours
- (2011) A R A Razak et al. BRITISH JOURNAL OF CANCER
- A phase II study of the histone deacetylase inhibitor vorinostat combined with tamoxifen for the treatment of patients with hormone therapy-resistant breast cancer
- (2011) P N Munster et al. BRITISH JOURNAL OF CANCER
- Targeting colon cancer stem cells using a new curcumin analogue, GO-Y030
- (2011) L Lin et al. BRITISH JOURNAL OF CANCER
- A randomized phase II study of two doses of vorinostat in combination with 5-FU/LV in patients with refractory colorectal cancer
- (2011) M. G. Fakih et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Progression of Prostate Carcinogenesis and Dietary Methyl Donors: Temporal Dependence
- (2011) S. Shabbeer et al. Cancer Prevention Research
- Combined inhibition of DNA methyltransferase and histone deacetylase restores caspase-8 expression and sensitizes SCLC cells to TRAIL
- (2011) Vitaliy O. Kaminskyy et al. CARCINOGENESIS
- (-)-Epigallocatechin-3-gallate reactivates silenced tumor suppressor genes, Cip1/p21 and p16INK4a, by reducing DNA methylation and increasing histones acetylation in human skin cancer cells
- (2011) V. Nandakumar et al. CARCINOGENESIS
- Schedule-dependent synergy of histone deacetylase inhibitors with DNA damaging agents in small cell lung cancer
- (2011) Victoria L. Luchenko et al. CELL CYCLE
- Regulation of chromatin by histone modifications
- (2011) Andrew J Bannister et al. CELL RESEARCH
- Epigenetic aberrations during oncogenesis
- (2011) Maria Hatziapostolou et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- DNA hypermethylation as a chemotherapy target
- (2011) Juan Ren et al. CELLULAR SIGNALLING
- Phase I Study of Decitabine in Combination with Vorinostat in Patients with Advanced Solid Tumors and Non-Hodgkin's Lymphomas
- (2011) Anastasios Stathis et al. CLINICAL CANCER RESEARCH
- Epigenetic-Based Therapies in Cancer
- (2011) Sang-Hyun Song et al. DRUGS
- Hormonal Therapy Promotes Hormone-Resistant Phenotype by Increasing DNMT Activity and Expression in Prostate Cancer Models
- (2011) Giovanni Luca Gravina et al. ENDOCRINOLOGY
- Decitabine, independent of apoptosis, exerts its cytotoxic effects on cell growth in melanoma cells
- (2011) Qian-Ying Liu et al. ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY
- The depletion of DNA methyltransferase-1 and the epigenetic effects of 5-aza-2’deoxycytidine (decitabine) are differentially regulated by cell cycle progression
- (2011) Mazin Al-Salihi et al. Epigenetics
- Entinostat for treatment of solid tumors and hematologic malignancies
- (2011) Jeffrey Knipstein et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Aminoguanidine and curcumin attenuated tumor necrosis factor (TNF)-α-induced oxidative stress, colitis and hepatotoxicity in mice
- (2011) Souad Mouzaoui et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Epigenetic regulation by decitabine of melanoma differentiation in vitro and in vivo
- (2011) Oscar Alcazar et al. INTERNATIONAL JOURNAL OF CANCER
- Phase II Study of Vorinostat for Treatment of Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma and Mantle Cell Lymphoma
- (2011) Mark Kirschbaum et al. JOURNAL OF CLINICAL ONCOLOGY
- Epigenetic regulation of DNA methyltransferases: DNMT1 and DNMT3B in gliomas
- (2011) Ganeshkumar Rajendran et al. JOURNAL OF NEURO-ONCOLOGY
- Epigenetic Regulation of Motor Neuron Cell Death through DNA Methylation
- (2011) B. A. Chestnut et al. JOURNAL OF NEUROSCIENCE
- Assessment of Objective Responses Using Volumetric Evaluation in Advanced Thymic Malignancies and Metastatic Non-small Cell Lung Cancer
- (2011) Jeremy Force et al. Journal of Thoracic Oncology
- Mocetinostat for relapsed classical Hodgkin's lymphoma: an open-label, single-arm, phase 2 trial
- (2011) Anas Younes et al. LANCET ONCOLOGY
- Acquired alpha thalassemia myelodyslastic/myeloproliferative syndrome (ATMDS): Evolution on hypomethylating agent therapy
- (2011) Christian Rose et al. LEUKEMIA RESEARCH
- LBH-589 (panobinostat) potentiates fludarabine anti-leukemic activity through a JNK- and XIAP-dependent mechanism
- (2011) Roberto Rosato et al. LEUKEMIA RESEARCH
- Histone méthyltransférases
- (2011) Hassiba Chaib et al. M S-MEDECINE SCIENCES
- Synergistic apoptotic effect of Arabinoxylan rice bran (MGN-3/Biobran) and Curcumin (Turmeric) on human multiple myeloma cell line U266 in vitro
- (2011) M. GHONEUM et al. NEOPLASMA
- Phase II trial of vorinostat in combination with bortezomib in recurrent glioblastoma: a north central cancer treatment group study
- (2011) B. B. Friday et al. NEURO-ONCOLOGY
- A phase I/II trial of the histone deacetylase inhibitor romidepsin for adults with recurrent malignant glioma: North American Brain Tumor Consortium Study 03-03
- (2011) Fabio M. Iwamoto et al. NEURO-ONCOLOGY
- Impact of Curcumin, Raspberry Extract, and Neem Leaf Extract on Rel Protein-Regulated Cell Death/Radiosensitization in Pancreatic Cancer Cells
- (2011) Jamunarani Veeraraghavan et al. PANCREAS
- Azacytidine and Decitabine Induce Gene-Specific and Non-Random DNA Demethylation in Human Cancer Cell Lines
- (2011) Sabine Hagemann et al. PLoS One
- On the Evolutionary Origin of Eukaryotic DNA Methyltransferases and Dnmt2
- (2011) Tomasz P. Jurkowski et al. PLoS One
- Gastrointestinal toxicity of vorinostat: reanalysis of phase 1 study results with emphasis on dose-volume effects of pelvic radiotherapy
- (2011) Åse Bratland et al. Radiation Oncology
- Failure of Hypomethylating Agent–Based Therapy in Myelodysplastic Syndromes
- (2011) Tapan M. Kadia et al. SEMINARS IN ONCOLOGY
- Epigenetic regulation of prostate cancer
- (2011) Suyin P. Chin et al. Clinical Epigenetics
- Treatment of poor-risk myelodysplastic syndromes and acute myeloid leukemia with a combination of 5-azacytidine and valproic acid
- (2011) Andrea Kuendgen et al. Clinical Epigenetics
- The dicyclohexylamine salt of RG108 (N-phthalyl-L-tryptophan), a potential epigenetic modulator
- (2010) Julie Braun et al. ACTA CRYSTALLOGRAPHICA SECTION E-STRUCTURE REPORTS ONLINE
- Hydralazine and magnesium valproate as epigenetic treatment for myelodysplastic syndrome. Preliminary results of a phase-II trial
- (2010) Myrna Candelaria et al. ANNALS OF HEMATOLOGY
- Histone deacetylases are critical targets of bortezomib-induced cytotoxicity in multiple myeloma
- (2010) J. Kikuchi et al. BLOOD
- Preclinical anti-myeloma activity of the novel HDAC-inhibitor JNJ-26481585
- (2010) Thorsten Stühmer et al. BRITISH JOURNAL OF HAEMATOLOGY
- The class-I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6-independent mechanism
- (2010) Daniela Buglio et al. BRITISH JOURNAL OF HAEMATOLOGY
- Phase 2 trial of the histone deacetylase inhibitor romidepsin for the treatment of refractory multiple myeloma
- (2010) Ruben Niesvizky et al. CANCER
- The effects of the histone deacetylase inhibitor romidepsin (FK228) are enhanced by aspirin (ASA) in COX-1 positive ovarian cancer cells through augmentation of p21
- (2010) Deok-Soo Son et al. CANCER BIOLOGY & THERAPY
- SIRT3 Is a Mitochondria-Localized Tumor Suppressor Required for Maintenance of Mitochondrial Integrity and Metabolism during Stress
- (2010) Hyun-Seok Kim et al. CANCER CELL
- The histone deacetylase inhibitor suberoylanilide hydroxamic acid induces growth inhibition and enhances taxol-induced cell death in breast cancer
- (2010) Yi-kang Shi et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Structure and Function of Mammalian DNA Methyltransferases
- (2010) Renata Zofia Jurkowska et al. CHEMBIOCHEM
- New Anacardic Acid-Inspired Benzamides: Histone Lysine Acetyltransferase Activators
- (2010) José A. Souto et al. ChemMedChem
- Emerging Anticancer Therapeutic Targets and the Cardiovascular System
- (2010) Xuyang Peng et al. CIRCULATION RESEARCH
- Vorinostat Plus Bortezomib for the Treatment of Relapsed/Refractory Multiple Myeloma: A Case Series Illustrating Utility in Clinical Practice
- (2010) Amitabha Mazumder et al. Clinical Lymphoma Myeloma & Leukemia
- Possible links between intestinal permeablity and food processing: a potential therapeutic niche for glutamine
- (2010) Jean Robert Rapin et al. Clinics
- Molecular and Enzymatic Profiles of Mammalian DNA Methyltransferases: Structures and Targets for Drugs
- (2010) F. Xu et al. CURRENT MEDICINAL CHEMISTRY
- Vorinostat in acute myeloid leukemia and myelodysplastic syndromes
- (2010) Thomas Prebet et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- RNA methylation by Dnmt2 protects transfer RNAs against stress-induced cleavage
- (2010) M. Schaefer et al. GENES & DEVELOPMENT
- Activity of deacetylase inhibitor panobinostat (LBH589) in cutaneous T-cell lymphoma models: Defining molecular mechanisms of resistance
- (2010) Wenlin Shao et al. INTERNATIONAL JOURNAL OF CANCER
- Phase I study of vorinostat (suberoylanilide hydroxamic acid, NSC 701852) in combination with docetaxel in patients with advanced and relapsed solid malignancies
- (2010) Bryan J. Schneider et al. INVESTIGATIONAL NEW DRUGS
- Breast Cancer Epigenetics: From DNA Methylation to microRNAs
- (2010) Jürgen Veeck et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Discovery of 2-(6-{[(6-Fluoroquinolin-2-yl)methyl]amino}bicyclo[3.1.0]hex-3-yl)-N-hydroxypyrimidine-5-carboxamide (CHR-3996), a Class I Selective Orally Active Histone Deacetylase Inhibitor
- (2010) David Moffat et al. JOURNAL OF MEDICINAL CHEMISTRY
- Phase II Study of the Histone Deacetylase Inhibitor Romidepsin in Relapsed Small Cell Lung Cancer (Cancer and Leukemia Group B 30304)
- (2010) Gregory A. Otterson et al. Journal of Thoracic Oncology
- Vorinostat, a histone deacetylase inhibitor, combined with pelvic palliative radiotherapy for gastrointestinal carcinoma: the Pelvic Radiation and Vorinostat (PRAVO) phase 1 study
- (2010) Anne Hansen Ree et al. LANCET ONCOLOGY
- Histone deacetylase inhibitors (HDACIs). Structure-activity relationships: history and new QSAR perspectives
- (2010) Eleni Pontiki et al. MEDICINAL RESEARCH REVIEWS
- Demethylating agent 5-aza-2-deoxycytidine enhances susceptibility of breast cancer cells to anticancer agents
- (2010) Sameer Mirza et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- SB939, a Novel Potent and Orally Active Histone Deacetylase Inhibitor with High Tumor Exposure and Efficacy in Mouse Models of Colorectal Cancer
- (2010) V. Novotny-Diermayr et al. MOLECULAR CANCER THERAPEUTICS
- The Histone Deacetylase Inhibitor MGCD0103 Induces Apoptosis in B-Cell Chronic Lymphocytic Leukemia Cells through a Mitochondria-Mediated Caspase Activation Cascade
- (2010) V. El-Khoury et al. MOLECULAR CANCER THERAPEUTICS
- Antiretroviral Intensification and Valproic Acid Lack Sustained Effect on Residual HIV-1 Viremia or Resting CD4+ Cell Infection
- (2010) Nancie M. Archin et al. PLoS One
- Combination of Suberoylanilide Hydroxamic Acid and Ritonavir is Effective Against Renal Cancer Cells
- (2010) Akinori Sato et al. UROLOGY
- A phase II multiple dose clinical trial of histone deacetylase inhibitor ITF2357 in patients with relapsed or progressive multiple myeloma
- (2009) Monica Galli et al. ANNALS OF HEMATOLOGY
- Design, synthesis, inhibitory activity, and binding mode study of novel DNA methyltransferase 1 inhibitors
- (2009) Takayoshi Suzuki et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells
- (2009) W. Fiskus et al. BLOOD
- Early epigenetic changes and DNA damage do not predict clinical response in an overlapping schedule of 5-azacytidine and entinostat in patients with myeloid malignancies
- (2009) T. E. Fandy et al. BLOOD
- Phase II study of the histone deacetylase inhibitor MGCD0103 in patients with previously treated chronic lymphocytic leukaemia
- (2009) Kristie A. Blum et al. BRITISH JOURNAL OF HAEMATOLOGY
- A New Class of Quinoline-Based DNA Hypomethylating Agents Reactivates Tumor Suppressor Genes by Blocking DNA Methyltransferase 1 Activity and Inducing Its Degradation
- (2009) J. Datta et al. CANCER RESEARCH
- The Emerging Therapeutic Potential of Histone Methyltransferase and Demethylase Inhibitors
- (2009) Astrid Spannhoff et al. ChemMedChem
- Molecular Modeling and Molecular Dynamics Studies of Hydralazine with Human DNA Methyltransferase 1
- (2009) Narender Singh et al. ChemMedChem
- Solving the Dnmt2 enigma
- (2009) Matthias Schaefer et al. CHROMOSOMA
- Potentiation of a Topoisomerase I Inhibitor, Karenitecin, by the Histone Deacetylase Inhibitor Valproic Acid in Melanoma: Translational and Phase I/II Clinical Trial
- (2009) A. I. Daud et al. CLINICAL CANCER RESEARCH
- Phase I Study of MG98, an Oligonucleotide Antisense Inhibitor of Human DNA Methyltransferase 1, Given as a 7-Day Infusion in Patients with Advanced Solid Tumors
- (2009) R. Plummer et al. CLINICAL CANCER RESEARCH
- Phase I Study of Vorinostat in Combination with Bortezomib for Relapsed and Refractory Multiple Myeloma
- (2009) A. Badros et al. CLINICAL CANCER RESEARCH
- JNJ-26481585, a Novel "Second-Generation" Oral Histone Deacetylase Inhibitor, Shows Broad-Spectrum Preclinical Antitumoral Activity
- (2009) J. Arts et al. CLINICAL CANCER RESEARCH
- Development of DNA Methyltransferase Inhibitors for the Treatment of Neoplastic Diseases
- (2009) Tamer Fandy CURRENT MEDICINAL CHEMISTRY
- Valproic acid (VPA), a histone deacetylase (HDAC) inhibitor, diminishes lymphoproliferation in the Fas -deficient MRL/lpr−/− murine model of autoimmune lymphoproliferative syndrome (ALPS)
- (2009) Kennichi C. Dowdell et al. EXPERIMENTAL HEMATOLOGY
- Sirtuin inhibitors
- (2009) Francisco J Alcaín et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- The conserved role of sirtuins in chromatin regulation
- (2009) Alejandro Vaquero INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY
- Vorinostat in solid and hematologic malignancies
- (2009) David Siegel et al. Journal of Hematology & Oncology
- Discovery of a 2,4-Diamino-7-aminoalkoxyquinazoline as a Potent and Selective Inhibitor of Histone Lysine Methyltransferase G9a
- (2009) Feng Liu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Antileukemic activity of valproic acid in chronic lymphocytic leukemia B cells defined by microarray analysis
- (2009) B Stamatopoulos et al. LEUKEMIA
- Preclinical antileukemia activity of JNJ-26481585, a potent second-generation histone deacetylase inhibitor
- (2009) Wei-Gang Tong et al. LEUKEMIA RESEARCH
- The HDAC inhibitor panobinostat (LBH589) inhibits mesothelioma and lung cancer cells in vitro and in vivo with particular efficacy for small cell lung cancer
- (2009) M. C. Crisanti et al. MOLECULAR CANCER THERAPEUTICS
- Protein methyltransferases as a target class for drug discovery
- (2009) Robert A. Copeland et al. NATURE REVIEWS DRUG DISCOVERY
- Histone deacetylase inhibitors induce thyroid cancer-specific apoptosis through proteasome-dependent inhibition of TRAIL degradation
- (2009) E Borbone et al. ONCOGENE
- Phase 2 study of sodium phenylbutyrate in ALS
- (2008) Merit E. Cudkowicz et al. Amyotrophic Lateral Sclerosis
- Epigenetics, DNA Methylation, and Chromatin Modifying Drugs
- (2008) Moshe Szyf Annual Review of Pharmacology and Toxicology
- The Anticancer Agent Chaetocin Is a Competitive Substrate and Inhibitor of Thioredoxin Reductase
- (2008) Jennifer D. Tibodeau et al. ANTIOXIDANTS & REDOX SIGNALING
- Determination of the class and isoform selectivity of small-molecule histone deacetylase inhibitors
- (2008) Nagma Khan et al. BIOCHEMICAL JOURNAL
- Chemical mechanisms of histone lysine and arginine modifications
- (2008) Brian C. Smith et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- 2-Trifluoroacetylthiophenes, a novel series of potent and selective class II histone deacetylase inhibitors
- (2008) Philip Jones et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells
- (2008) A. Scuto et al. BLOOD
- Phase 1 study of the oral isotype specific histone deacetylase inhibitor MGCD0103 in leukemia
- (2008) G. Garcia-Manero et al. BLOOD
- Will histone deacetylase inhibitors require combination with other agents to fulfil their therapeutic potential?
- (2008) L Nolan et al. BRITISH JOURNAL OF CANCER
- Valproate synergizes with purine nucleoside analogues to induce apoptosis of B-chronic lymphocytic leukaemia cells
- (2008) Amel Baya Bouzar et al. BRITISH JOURNAL OF HAEMATOLOGY
- Histone deacetylase inhibitors: Mechanisms of cell death and promise in combination cancer therapy
- (2008) Jennifer S. Carew et al. CANCER LETTERS
- Induction of Pluripotent Stem Cells from Mouse Embryonic Fibroblasts by Oct4 and Klf4 with Small-Molecule Compounds
- (2008) Yan Shi et al. Cell Stem Cell
- Synthesis of Benzamides Related to Anacardic Acid and Their Histone Acetyltransferase (HAT) Inhibitory Activities
- (2008) José A. Souto et al. ChemMedChem
- Histone deacetylase inhibitors: the anticancer, antimetastatic and antiangiogenic activities of AN-7 are superior to those of the clinically tested AN-9 (Pivanex)
- (2008) Nataly Tarasenko et al. CLINICAL & EXPERIMENTAL METASTASIS
- A Phase I and Pharmacokinetic Study of the Oral Histone Deacetylase Inhibitor, MS-275, in Patients with Refractory Solid Tumors and Lymphomas
- (2008) L. Gore et al. CLINICAL CANCER RESEARCH
- Clinical and Molecular Responses in Lung Cancer Patients Receiving Romidepsin
- (2008) D. S. Schrump et al. CLINICAL CANCER RESEARCH
- A Phase I Biological Study of MG98, an Oligodeoxynucleotide Antisense to DNA Methyltransferase 1, in Patients with High-Risk Myelodysplasia and Acute Myeloid Leukemia
- (2008) R. B. Klisovic et al. CLINICAL CANCER RESEARCH
- Tolerability, Pharmacodynamics, and Pharmacokinetics Studies of Depsipeptide (Romidepsin) in Patients with Acute Myelogenous Leukemia or Advanced Myelodysplastic Syndromes
- (2008) V. M. Klimek et al. CLINICAL CANCER RESEARCH
- Histone Deacetylase Inhibitor Panobinostat Induces Clinical Responses with Associated Alterations in Gene Expression Profiles in Cutaneous T-Cell Lymphoma
- (2008) L. Ellis et al. CLINICAL CANCER RESEARCH
- Chemical Origins of Isoform Selectivity in Histone Deacetylase Inhibitors
- (2008) Alan Kozikowski et al. CURRENT PHARMACEUTICAL DESIGN
- Histone Deacetylase Inhibitors in Cancer Therapy: New Compounds and Clinical Update of Benzamide-Type Agents
- (2008) Oscar Moradei et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- A phase I clinical trial of the histone deacetylase inhibitor belinostat in patients with advanced hematological neoplasia
- (2008) Peter Gimsing et al. EUROPEAN JOURNAL OF HAEMATOLOGY
- Curcumin inhibits VEGF-mediated angiogenesis in human intestinal microvascular endothelial cells through COX-2 and MAPK inhibition
- (2008) D G Binion et al. GUT
- A phase II study of vorinostat in the treatment of persistent or recurrent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study
- (2008) Susan C. Modesitt et al. GYNECOLOGIC ONCOLOGY
- Epi-drugs to fight cancer: From chemistry to cancer treatment, the road ahead
- (2008) Antonello Mai et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Cancer treatment of the future: Inhibitors of histone methyltransferases
- (2008) Astrid Spannhoff et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Phase II trial of romidepsin (NSC-630176) in previously treated colorectal cancer patients with advanced disease: a Southwest Oncology Group study (S0336)
- (2008) Robert P. Whitehead et al. INVESTIGATIONAL NEW DRUGS
- Phase I Study of MGCD0103 Given As a Three-Times-Per-Week Oral Dose in Patients With Advanced Solid Tumors
- (2008) Lillian L. Siu et al. JOURNAL OF CLINICAL ONCOLOGY
- Structural Origin of Selectivity in Class II-Selective Histone Deacetylase Inhibitors
- (2008) Guillermina Estiu et al. JOURNAL OF MEDICINAL CHEMISTRY
- Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial
- (2008) Shanu Kohli Kurd et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Phase I trial of oral vorinostat (suberoylanilide hydroxamic acid, SAHA) in patients with advanced multiple myeloma
- (2008) Paul Richardson et al. LEUKEMIA & LYMPHOMA
- The use of diversity profiling to characterize chemical modulators of the histone deacetylases
- (2008) Leonard Blackwell et al. LIFE SCIENCES
- MGCD0103, a novel isotype-selective histone deacetylase inhibitor, has broad spectrum antitumor activity in vitro and in vivo
- (2008) M. Fournel et al. MOLECULAR CANCER THERAPEUTICS
- Roles of the EZH2 histone methyltransferase in cancer epigenetics
- (2008) Jeffrey A. Simon et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Demethylating Agent 5-Aza-2′-Deoxycytidine Enhances Susceptibility of Bladder Transitional Cell Carcinoma to Cisplatin
- (2008) Donghao Shang et al. UROLOGY
- Histone acetylation and chromatin signature in stem cell identity and cancer
- (2007) Vivek Shukla et al. MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS
- Depsipeptide (FK228) inhibits growth of human prostate cancer cells
- (2007) Ming-Tsung Lai et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now